- Home
- FATE vs JHI Comparison
FATE vs JHI Comparison
Compare FATE & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- JHI
- Stock Information
- Founded
- FATE 2007
- JHI 1971
- Country
- FATE United States
- JHI United States
- Employees
- FATE N/A
- JHI N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- JHI Trusts Except Educational Religious and Charitable
- Sector
- FATE Health Care
- JHI Finance
- Exchange
- FATE Nasdaq
- JHI Nasdaq
- Market Cap
- FATE 142.4M
- JHI 124.2M
- IPO Year
- FATE 2013
- JHI N/A
- Fundamental
- Price
- FATE $1.42
- JHI $14.13
- Analyst Decision
- FATE Hold
- JHI
- Analyst Count
- FATE 10
- JHI 0
- Target Price
- FATE $6.75
- JHI N/A
- AVG Volume (30 Days)
- FATE 2.1M
- JHI 29.5K
- Earning Date
- FATE 03-04-2025
- JHI 01-01-0001
- Dividend Yield
- FATE N/A
- JHI 6.80%
- EPS Growth
- FATE N/A
- JHI N/A
- EPS
- FATE N/A
- JHI 1.05
- Revenue
- FATE $13,447,000.00
- JHI N/A
- Revenue This Year
- FATE N/A
- JHI N/A
- Revenue Next Year
- FATE N/A
- JHI N/A
- P/E Ratio
- FATE N/A
- JHI $12.47
- Revenue Growth
- FATE N/A
- JHI N/A
- 52 Week Low
- FATE $1.04
- JHI $11.63
- 52 Week High
- FATE $8.83
- JHI $13.40
- Technical
- Relative Strength Index (RSI)
- FATE 48.76
- JHI 53.98
- Support Level
- FATE $1.43
- JHI $14.15
- Resistance Level
- FATE $1.81
- JHI $14.24
- Average True Range (ATR)
- FATE 0.14
- JHI 0.08
- MACD
- FATE 0.05
- JHI 0.00
- Stochastic Oscillator
- FATE 39.06
- JHI 54.17
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.